FIELD: medicine.
SUBSTANCE: invention concerns the new synthetic oxidised lipids and ways of application of the oxidised lipids for treatment and inflammation prevention, associated with endogenous oxidised lipid.
EFFECT: rising of treatment efficiency.
54 cl, 25 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS | 2009 |
|
RU2482854C2 |
| OXIDISED LIPID COMPOUNDS AND THEIR APPLICATION | 2009 |
|
RU2532546C2 |
| IMPROVED METHOD FOR SYNTHESIS OF OXIDISED PHOSPHOLIPIDS | 2005 |
|
RU2399626C2 |
| LIPID COMPOUND AND COMPOSITION BASED THEREON | 2021 |
|
RU2825571C1 |
| METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES | 2005 |
|
RU2414236C2 |
| PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
| THERAPEUTIC AGENTS AND METHODS FOR THE TREATMENT OF TLR2-MEDIATED DISEASES AND DISORDERS | 2019 |
|
RU2791022C2 |
| CAVITATION NUCLEUS FOR DRUG DELIVERY AND METHOD FOR DRUG DELIVERY USING SAME | 2016 |
|
RU2704823C2 |
| NANOPARTICLE BASED, TUMOUR-TARGETED DELIVERY OF MEDICINAL AGENTS | 2011 |
|
RU2593367C2 |
| METHOD OF REVERSIBLE INHIBITION IN TUMOR CELLS OF HEPATOCELLULAR CARCINOMA OF GENE EXPRESSION CODING SYNTHESIS OF APOLIPOPROTEIN B | 2018 |
|
RU2699172C1 |
